129 related articles for article (PubMed ID: 6589010)
1. Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia.
Nilsson B
Br J Haematol; 1984 Jul; 57(3):365-71. PubMed ID: 6589010
[TBL] [Abstract][Full Text] [Related]
2. The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia.
Fontana JA; Rogers JS; Durham JP
Cancer; 1986 Jan; 57(2):209-17. PubMed ID: 3455835
[TBL] [Abstract][Full Text] [Related]
3. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
Stone RM; Maguire M; Goldberg MA; Antin JH; Rosenthal DS; Mayer RJ
Blood; 1988 Mar; 71(3):690-6. PubMed ID: 3422828
[TBL] [Abstract][Full Text] [Related]
4. [Proliferation and differentiation of cells and differentiation- inducing treatment in leukemia].
Kuliczkowski K
Pol Arch Med Wewn; 1992 Jul; 88(1):49-56. PubMed ID: 1454660
[No Abstract] [Full Text] [Related]
5. Treatment of refractory undifferentiated acute myelogenous leukemia with all-trans-retinoic acid.
Griggs JJ; Henley SE; Rowe JM
Am J Hematol; 1994 Feb; 45(2):177-80. PubMed ID: 8141124
[TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations.
Flynn PJ; Miller WJ; Weisdorf DJ; Arthur DC; Brunning R; Branda RF
Blood; 1983 Dec; 62(6):1211-7. PubMed ID: 6580050
[TBL] [Abstract][Full Text] [Related]
8. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Huang ME; Ye YC; Chen SR; Chai JR; Lu JX; Zhoa L; Gu LJ; Wang ZY
Blood; 1988 Aug; 72(2):567-72. PubMed ID: 3165295
[TBL] [Abstract][Full Text] [Related]
9. Differentiation induction in myelodysplasia and acute myeloid leukaemia: use of synergistic drug combinations.
Francis GE; Mufti GJ; Knowles SM; Berney JJ; Guimaraes JE; Secker-Walker LM; Hamblin TJ
Leuk Res; 1987; 11(11):971-7. PubMed ID: 3480401
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia.
Daenen S; Vellenga E; van Dobbenburgh OA; Halie MR
Blood; 1986 Feb; 67(2):559-61. PubMed ID: 3455829
[TBL] [Abstract][Full Text] [Related]
12. [Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
Lengfelder E; Simon M; Haase D; Hild F; Hehlmann R
Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1143-50. PubMed ID: 8076501
[TBL] [Abstract][Full Text] [Related]
13. Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemia.
Amato R; Kantarjian H; Walters R; Keating M
Cancer; 1988 Feb; 61(4):650-3. PubMed ID: 3422175
[TBL] [Abstract][Full Text] [Related]
14. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence of all-trans retinoic acid inducing maturation in acute promyelocytic leukaemia.
Hamidah HN; Cheong SK; Ainoon O
Acta Haematol; 1993; 89(1):50-1. PubMed ID: 8480488
[TBL] [Abstract][Full Text] [Related]
16. The combined effects of all-trans retinoic acid and granulocyte colony-stimulating factor as a differentiation induction therapy for acute promyelocytic leukemia.
Tsurumi H; Tojo A; Takahashi T; Moriwaki H; Asano S; Muto Y
Intern Med; 1993 Aug; 32(8):648-50. PubMed ID: 7508772
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
[TBL] [Abstract][Full Text] [Related]
18. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
[TBL] [Abstract][Full Text] [Related]
19. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
[TBL] [Abstract][Full Text] [Related]
20. Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.
Gillis JC; Goa KL
Drugs; 1995 Nov; 50(5):897-923. PubMed ID: 8586032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
